Cargando…
Boon and bane of remission induction with rituximab in ANCA-associated vasculitis: lessons learned from the RAVE-ITN follow-up study
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nickan Research Institute
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206041/ https://www.ncbi.nlm.nih.gov/pubmed/25340156 http://dx.doi.org/10.12861/jrip.2014.05 |
| _version_ | 1782340760304091136 |
|---|---|
| author | Kronbichler, Andreas |
| author_facet | Kronbichler, Andreas |
| author_sort | Kronbichler, Andreas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4206041 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Nickan Research Institute |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42060412014-10-22 Boon and bane of remission induction with rituximab in ANCA-associated vasculitis: lessons learned from the RAVE-ITN follow-up study Kronbichler, Andreas J Renal Inj Prev Epidemiology and Prevention Nickan Research Institute 2013-11-02 /pmc/articles/PMC4206041/ /pubmed/25340156 http://dx.doi.org/10.12861/jrip.2014.05 Text en Copyright © 2014 The Author(s); Published by Nickan Research Institute http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Epidemiology and Prevention Kronbichler, Andreas Boon and bane of remission induction with rituximab in ANCA-associated vasculitis: lessons learned from the RAVE-ITN follow-up study |
| title | Boon and bane of remission induction with rituximab in ANCA-associated vasculitis: lessons learned from the RAVE-ITN follow-up study |
| title_full | Boon and bane of remission induction with rituximab in ANCA-associated vasculitis: lessons learned from the RAVE-ITN follow-up study |
| title_fullStr | Boon and bane of remission induction with rituximab in ANCA-associated vasculitis: lessons learned from the RAVE-ITN follow-up study |
| title_full_unstemmed | Boon and bane of remission induction with rituximab in ANCA-associated vasculitis: lessons learned from the RAVE-ITN follow-up study |
| title_short | Boon and bane of remission induction with rituximab in ANCA-associated vasculitis: lessons learned from the RAVE-ITN follow-up study |
| title_sort | boon and bane of remission induction with rituximab in anca-associated vasculitis: lessons learned from the rave-itn follow-up study |
| topic | Epidemiology and Prevention |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206041/ https://www.ncbi.nlm.nih.gov/pubmed/25340156 http://dx.doi.org/10.12861/jrip.2014.05 |
| work_keys_str_mv | AT kronbichlerandreas boonandbaneofremissioninductionwithrituximabinancaassociatedvasculitislessonslearnedfromtheraveitnfollowupstudy |